De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to NRG Oncology
Related studies linked through entity extraction aliases.
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- Status
- RECRUITING
- Phase
- PHASE3
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3